209 related articles for article (PubMed ID: 21399658)
21. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
[TBL] [Abstract][Full Text] [Related]
22. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).
Cheng X; Liu Y; Chu H; Kao HY
J Biol Chem; 2012 Jul; 287(28):23356-67. PubMed ID: 22589541
[TBL] [Abstract][Full Text] [Related]
23. Dual regulation of Stat1 and Stat3 by the tumor suppressor protein PML contributes to interferon α-mediated inhibition of angiogenesis.
Hsu KS; Zhao X; Cheng X; Guan D; Mahabeleshwar GH; Liu Y; Borden E; Jain MK; Kao HY
J Biol Chem; 2017 Jun; 292(24):10048-10060. PubMed ID: 28432122
[TBL] [Abstract][Full Text] [Related]
24. Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells.
Sun F; Chan E; Wu Z; Yang X; Marquez VE; Yu Q
Mol Cancer Ther; 2009 Dec; 8(12):3191-202. PubMed ID: 19934278
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes.
Sakamoto S; Potla R; Larner AC
J Biol Chem; 2004 Sep; 279(39):40362-7. PubMed ID: 15194680
[TBL] [Abstract][Full Text] [Related]
26. Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation.
Li F; Wu R; Cui X; Zha L; Yu L; Shi H; Xue B
J Biol Chem; 2016 Feb; 291(9):4523-36. PubMed ID: 26733201
[TBL] [Abstract][Full Text] [Related]
27. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
28. [A novel molecular mechanism of interferon alpha-regulated expression of retinoic acid-induced gene G].
Lou YJ; Pan XR; Jia PM; Li D; Zhang ZL; Xu GP; Tong JH
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):88-92. PubMed ID: 20403236
[TBL] [Abstract][Full Text] [Related]
29. Global changes in STAT target selection and transcription regulation upon interferon treatments.
Hartman SE; Bertone P; Nath AK; Royce TE; Gerstein M; Weissman S; Snyder M
Genes Dev; 2005 Dec; 19(24):2953-68. PubMed ID: 16319195
[TBL] [Abstract][Full Text] [Related]
30. Role of metazoan mediator proteins in interferon-responsive transcription.
Lau JF; Nusinzon I; Burakov D; Freedman LP; Horvath CM
Mol Cell Biol; 2003 Jan; 23(2):620-8. PubMed ID: 12509459
[TBL] [Abstract][Full Text] [Related]
31. Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes.
Radaeva S; Jaruga B; Hong F; Kim WH; Fan S; Cai H; Strom S; Liu Y; El-Assal O; Gao B
Gastroenterology; 2002 Apr; 122(4):1020-34. PubMed ID: 11910354
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells.
Grimaldi G; Christian M; Steel JH; Henriet P; Poutanen M; Brosens JJ
Mol Endocrinol; 2011 Nov; 25(11):1892-903. PubMed ID: 21903722
[TBL] [Abstract][Full Text] [Related]
33. Identification of a novel conserved motif in the STAT family that is required for tyrosine phosphorylation.
Gamero AM; Sakamoto S; Montenegro J; Larner AC
J Biol Chem; 2004 Mar; 279(13):12379-85. PubMed ID: 14722125
[TBL] [Abstract][Full Text] [Related]
34. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
[TBL] [Abstract][Full Text] [Related]
35. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.
Chen H; Tu SW; Hsieh JT
J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459
[TBL] [Abstract][Full Text] [Related]
37. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
38. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
39. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; Pützer BM
Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
